Start
Projects
CRO Services
About us
Contact
News
Mehr
13. June 2024
Applicant: MiHKAL GmbH
WO2024121253 - Novel N,N-Dimethyltryptamine (DMT) Derivatives And Uses Thereof
21. March 2024
Inventor: Dr. Matthias Grill
WO2024056678 - Novel nootropic prodrugs of Phenethylamine
Funding highlights the broader recognition of psychedelic therapies
07. January 2024
A Milestone for Psychedelic Research and Therapy
08. September 2023
Tracing Back the Footsteps of Albert Hofmann
17. April 2023
07. April 2023
31.March 2023
20. May 2022
Drogenstadt Basel
17. March 2022
WO2022053696 - Novel Safrylamine derivates having prodrug properties
09. March 2022
In a video Interview, Dr. Matthias Grill is talking about MiHKAL and the collaboration with COMPASS
24. February 2022
COMPASS pathways announces financial results for the year 2021 and is highlighting the pipeline development with MiHKAL GmbH
W02022038299 - Novel Psilocin derivates having prodrug properties
02. February 2022
Mit Partydrogen gegen Depression
13. January 2022
W02022008627 - Improved method for the production of lysergic acid diethylamide (LSD) and novel derivatives thereof
14. September 2021
COMPASS Pathways has acquired an intellectual property portfolio from MiHKAL, who will be working with COMPASS on an exclusive research project to develop new product candidates.
22. March 2021
MiHKAL is founded
